Sign in
4/A

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000276

EVP, Chief Development Officer sold 1,680 shares at $75.05 ($126,091)

  • EVP, Chief Development Officer acquired 1,680 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-03 Exercise or conversion : show line 1 in the form 10b5-1 +775 $60.89 $47,190 60,432 D
2025-11-03 Sale : show line 2 in the form 10b5-1 −775 $75.05 $58,167 59,657 D
2025-11-03 Exercise or conversion : show line 3 in the form 10b5-1 +905 $56.78 $51,386 60,562 D
2025-11-03 Sale : show line 4 in the form 10b5-1 −905 $75.05 $67,924 59,657 D
Open-market sales · 1,680 sh · avg $75.05 · $126,091

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-11-03 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −905 15,538 D
2025-11-03 Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −775 19,101 D
Loading xslF345X05/edgardoc.xml…